Health and Medical

AlphaVax’s core technology – the alphavirus vector platform – is a proprietary system for delivering genetic material to stimulate targeted immune responses. This platform is designed for rapid vaccine development and offers the potential for broad applicability across various infectious diseases and cancer therapies.

Alphavaccine Vector Platform

Science and Engineering

Biotechnology

AlphaVax

North Carolina

Biopharma

Life Science

AlphaVax provides custom vaccine development services to pharmaceutical and biotechnology companies. Leveraging our expertise in vector technology and immunological research, we offer support from preclinical development through early clinical trials.

Vaccine Development Services

Other products/services from AlphaVax

Alphavaccine Vector Platform

N/A